Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Inaxaplin [inn]
2. S2sj2rvz6y
3. 2446816-88-0
4. Unii-s2sj2rvz6y
5. Schembl22118376
6. Ex-a6319
7. Hy-132820
8. Cs-0204094
9. 3-(5,7-difluoro-2-(4-fluorophenyl)-1h-indol-3-yl)-n-((3s,4r)-4-hydroxy-2-oxopyrrolidin-3-yl)propanamide
| Molecular Weight | 417.4 g/mol |
|---|---|
| Molecular Formula | C21H18F3N3O3 |
| XLogP3 | 2.1 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 5 |
| Exact Mass | 417.13002593 g/mol |
| Monoisotopic Mass | 417.13002593 g/mol |
| Topological Polar Surface Area | 94.2 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 646 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
84
PharmaCompass offers a list of Inaxaplin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Inaxaplin manufacturer or Inaxaplin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Inaxaplin manufacturer or Inaxaplin supplier.
PharmaCompass also assists you with knowing the Inaxaplin API Price utilized in the formulation of products. Inaxaplin API Price is not always fixed or binding as the Inaxaplin Price is obtained through a variety of data sources. The Inaxaplin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A HY-132820 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of HY-132820, including repackagers and relabelers. The FDA regulates HY-132820 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. HY-132820 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A HY-132820 supplier is an individual or a company that provides HY-132820 active pharmaceutical ingredient (API) or HY-132820 finished formulations upon request. The HY-132820 suppliers may include HY-132820 API manufacturers, exporters, distributors and traders.
HY-132820 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of HY-132820 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right HY-132820 GMP manufacturer or HY-132820 GMP API supplier for your needs.
A HY-132820 CoA (Certificate of Analysis) is a formal document that attests to HY-132820's compliance with HY-132820 specifications and serves as a tool for batch-level quality control.
HY-132820 CoA mostly includes findings from lab analyses of a specific batch. For each HY-132820 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
HY-132820 may be tested according to a variety of international standards, such as European Pharmacopoeia (HY-132820 EP), HY-132820 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (HY-132820 USP).
